Biotechnology

METIS TECHBIO-P

Jitai Technology Signs Comprehensive Strategic Cooperation Agreement with Shali Bio

Jietai Tech IPO Oversubscribed Over 5148 Times with Margin Lending

METIS TECHBIO-P released FY2025 Annual Earnings on May 5, 2026 (BJT), with actual revenue of HKD 114.76 M and EPS of HKD -4.5508

METIS TECHBIO-P released FY2024 Annual Earnings on May 5, 2026 (BJT) with actual revenue of HKD 1.604 M and EPS of HKD 0

7666.HK released FY2023 Annual Earnings on May 5 Post-Market (BJT), actual revenue HKD 10.25 M, actual EPS HKD 0

HINSANG GROUP

RIVERINE CHINA

PASHUN INT RTS

BRAINAURORA-B

SOFTMEDX

GOLDENPOWER

ZHONGKE GROUP

VISION SYNERGY

GEMILANG INTL

GHPC

03336

07666

08299

02565

03317

02513

01879

02577

02218

02585

JU TENG INTL(03336) fell 25.93%, with a trading turnover 184.1 Million HKD, and a year-to-date rose 40.2%. METIS TECHBIO-P(07666) fell 14.13%, with a trading turnover 177.5 Million HKD, and a year-to-date rose 91%. GT GOLD(08299) fell 11%, with a trading turnover 24.9 Million HKD, and a year-to-date fell 12.7%.

Top Gainers&Losers

JU TENG INTL

GT GOLD

PEGBIO CO-B

XUNCE

KNOWLEDGE ATLAS

XIZHI TECH-P

INNOSCIENCE

ANDRE JUICE

MOKINGRAN

Top 10 HK Stock Losers (5.19)

02477

02940

02225

06869

02635

02726

02631

PEGBIO CO-B(02565) fell 18.5%, with a trading turnover 104.2 Million HKD, and a year-to-date fell 83.8%. WELLCELL HOLD(02477) fell 15.3%, with a trading turnover 362.7 Million HKD, and a year-to-date rose 38.8%. WELLCELL HOLD(02940) fell 14.83%, with a trading turnover 61.4 Million HKD, and a year-to-date rose 40.6%.

WELLCELL HOLD

JINHAI MED TECH

YOFC

NUOBIKAN

EPIWORLD

SICC

Top 10 HK Stock Losers (5.15)

METiS TechBio has made history by becoming the world's first publicly listed AI-powered drug delivery company on the Hong Kong Stock Exchange, raising over HKD 2.1 billion in its IPO. The offering was oversubscribed by more than 6,900 times, marking the largest healthcare IPO in Hong Kong for 2026. The company aims to revolutionize biomedicine with its proprietary AI nanodelivery platform, NanoForge, which supports innovative drug development across major disease areas. The IPO signifies a new era for AI in pharmaceuticals, attracting significant investment from global asset managers and specialized funds.

PR Newswire

Jefferies Financial

Deutsche Bank AG

CITIC SEC

CITIC Securities Co., Ltd.

BlackRock

UBS Group AG

ORIX Corporation

Orix

GF SEC

GF SECURITIES

ICBC

Waldencast

Deutsche Bank AG Subscription Rights

Deutsche Postbank AG

BlackRock Tech and Private Equity Term Trust

BLACKROCK MULTI-SECTOR INCOME TR COM USD0.001(S/R 09/09/2025) WI

Blackrock Enhanced Div Achievers Trust

BlackRock Science and Tech Term Trust

BlackRock Multi-Sector Income Trust

WALDENCAST PLC C/WTS 27/07/2027 (TO PUR ORD)

METiS TechBio, the World's First Publicly Listed AI-Powered Drug Delivery Company, Debuts on the Hong Kong Stock Exchange, "The SpaceX of Pharmaceuticals" Ushers in a New Era of Biopharmaceuticals

METIS TECHBIO-P+12.540 (+119.429%) closed at $29.4 on gray market yesterday, up 180.0% from the listing price of $10.5. On debut today, the stock opened at $28.68, up 173.1% from the listing price of $10.5, 48.63 million shares traded at market open.(HK stocks quote is delayed for at least 15 mins.)

AASTOCKS News

METIS TECHBIO-P Opens Up 173.1% to $28.68 on Debut

Metis TechBio-Popened at HKD32 in the grey market, 204.8% above its listing price, and is currently quoted at HKD30.76, reflecting a 193% gain. Trading volume reached 13.13 million shares, totaling HKD432 million. Another platform reported an opening at HKD25.1, with a current quote of HKD30.98, indicating a 195% gain over the listing price and a volume of 7.11 million shares worth HKD241 million.

Futu

FUTU-W

Metis TechBio-P  Opens at HKD32 in Grey Market, 204.8% Above Listing Price

METIS TECHBIO-P(07666.HK)

Top 10 HK Stock Losers (5.19)

Top 10 HK Stock Losers (5.15)

METiS TechBio, the World's First Publicly Listed AI-Powered Drug Delivery Company, Debuts on the Hong Kong Stock Exchange, "The SpaceX of Pharmaceuticals" Ushers in a New Era of Biopharmaceuticals

METIS TECHBIO-P Opens Up 173.1% to $28.68 on Debut

Metis TechBio-P Opens at HKD32 in Grey Market, 204.8% Above Listing Price